Stressing Out PanIN: NRF2 Pushes over the Edge

Slides:



Advertisements
Similar presentations
Charles Swanton, Julian Downward  Cancer Cell 
Advertisements

Obesity and Cancer: The Oil that Feeds the Flame
Adrienne D. Cox, Kenneth P. Olive  Cancer Cell 
Tissue Culture as a Hostile Environment: Identifying Conditions for Breast Cancer Progression Studies  Jerry W. Shay, Woodring E. Wright  Cancer Cell 
Warren S. Pear, M. Celeste Simon  Cancer Cell 
Jens T. Siveke, Roland M. Schmid  Cancer Cell 
mTOR Signaling in Melanoma: Oncogene-Induced Pseudo-Senescence?
NAD+ Supplementation as a Novel Approach to cURIng HCC?
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Stopping the Clock with MYC
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Volume 16, Issue 6, Pages (June 2015)
Figure 4 Oncogenic KRAS and inflammation
Cell tension, matrix mechanics, and cancer development
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
New Insights Into the Cell Lineage of Pancreatic Ductal Adenocarcinoma: Evidence for Tumor Stem Cells in Premalignant Lesions?  Janel L. Kopp, Maike Sander 
Deregulating EMT and Senescence: Double Impact by a Single Twist
The Wind God Promotes Lung Cancer
Shockingly Early: Chromatin-Mediated Loss of the Heat Shock Response
IDH1, Histone Methylation, and So Forth
Marco Demaria, Pierre Yves Desprez, Judith Campisi, Michael C. Velarde 
Tissue Culture as a Hostile Environment: Identifying Conditions for Breast Cancer Progression Studies  Jerry W. Shay, Woodring E. Wright  Cancer Cell 
Cellular Senescence in Cancer and Aging
Toru Furukawa  Clinical Gastroenterology and Hepatology 
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
p53 and Metabolism: The GAMT Connection
Ning Li, Sergei I. Grivennikov, Michael Karin  Cancer Cell 
Transcriptional Addiction in Cancer
Volume 36, Issue 1, Pages 2-14 (October 2009)
Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure
Capturing VCP: Another Molecular Piece in the ALS Jigsaw Puzzle
KLF4 Initiates Acinar Cell Reprogramming and Is Essential for the Early Stages of Pancreatic Carcinogenesis  Ravikanth Maddipati, Jonathan P. Katz  Cancer.
Roles for KRAS in Pancreatic Tumor Development and Progression
Rushika M. Perera, Nabeel Bardeesy  Cancer Cell 
David A. Tuveson, John P. Neoptolemos  Cell 
The Morphogenetic Code and Colon Cancer Development
Volume 153, Issue 6, Pages (June 2013)
Deregulating EMT and Senescence: Double Impact by a Single Twist
Volume 28, Issue 5, Pages (November 2015)
Entosis: It's a Cell-Eat-Cell World
Autophagy in the Pathogenesis of Disease
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
Sapna Puri, Alexandra E. Folias, Matthias Hebrok  Cell Stem Cell 
14-3-3ζ Turns TGF-β to the Dark Side
Dosage of Atg5 Gene Affects Pancreatic Tumorigenesis and Progression
Killing Lymphoma with Smac-Mimetics: As Easy as ABC?
A New FOXO Pathway Required for Leukemogenesis
Lifting the Mist on Gastric Stem Cells
Sapna Puri, Matthias Hebrok  Developmental Cell 
Easy Stress Relief by EZH2
Cellular Pliancy and the Multistep Process of Tumorigenesis
Elanor N. Wainwright, Paola Scaffidi  Trends in Cancer 
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
MicroRNA Functions in Stress Responses
Samirkumar B. Amin, Roel G.W. Verhaak  Cell Systems 
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Of Cilia and Cysts: Modeling Pancreatic Polycystic Disease
Volume 14, Issue 4, Pages (October 2008)
Inflammation, ROS, and Mutagenesis
Chronic Lymphocytic Leukemia: Keeping Cell Death at Bay
A FIRE-y PAGE in the Computational Analysis of Cancer Profiles
Kelsey J. Roberts, Aaron M. Kershner, Philip A. Beachy  Cancer Cell 
TFIID and MYB Share a Therapeutic Handshake in AML
Immunity, Inflammation, and Cancer
Hariharan Easwaran, Hsing-Chen Tsai, Stephen B. Baylin  Molecular Cell 
YAP1 Takes Over when Oncogenic K-Ras Slumbers
c-Raf in KRas Mutant Cancers: A Moving Target
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Gankyrin: An intriguing name for a novel regulator of p53 and RB
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Presentation transcript:

Stressing Out PanIN: NRF2 Pushes over the Edge Laura Torrente, Gina M. DeNicola  Cancer Cell  Volume 32, Issue 6, Pages 723-725 (December 2017) DOI: 10.1016/j.ccell.2017.11.014 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 Schematic Representation of Adaptive Cellular Mechanisms that Occur during the Stages Prior the Development of PDAC (Top) and the Respective Histological Alterations Observed in the Exocrine Pancreas (Bottom) Left: in normal tissues from healthy individuals, KEAP1 constitutively targets NRF2 for degradation, impeding newly synthetized NRF2 from reaching the nucleus to activate the transcription of its target genes. At the tissue level, acinar cells organize as clusters that share a central lumen, while ductal cells construct the epithelial lining of the tubes that traverses the pancreas to the duodenum. Middle: oncogenic activation of KRAS drives transdifferentiation of acinar cells to duct-like cells in a process known as acinar-to-ductal metaplasia (ADM), followed by progressive dysplasia that leads to the formation of premalignant lesions (PanIN). These changes are translated into the progressive loss of acinar cells and their replacement by highly proliferative ductal cells that harbor multiple somatic mutations. Sustained activation of KRAS increases the levels and activity of NRF2, which participates in the maintenance and progression of premalignant lesions. Right: additional cellular stresses that promote chronic inflammation alter autophagy flux, thereby triggering the accumulation of p62 and subsequent KEAP1 sequestration. Consequently, NRF2 evades proteasomal degradation and activates the transcription of MDM2, which in turn mediates p53 degradation and activates the Notch signaling pathway. p53 degradation thereby allows PanIN progression and PDAC formation by preventing the onset of senescence. Thus, KRAS mutation and defective autophagy co-operate to activate the NRF2 cascade, thereby promoting malignant transformation. Cancer Cell 2017 32, 723-725DOI: (10.1016/j.ccell.2017.11.014) Copyright © 2017 Elsevier Inc. Terms and Conditions